Alerts will be sent to your verified email
Verify Email
PGHL
|
Procter&Gamble Healt
|
Orchid Pharma
|
Aarti Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
54.51 % | n/a | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
33.88 % | -7.68 % | 17.79 % |
|
5yr average Equity Multiplier
|
2.59 | 0.59 | 2.0 |
|
5yr Average Asset Turnover Ratio
|
0.52 | 0.38 | 0.7 |
|
5yr Avg Net Profit Margin
|
34.2 % | -6.96 % | 12.79 % |
|
Price to Book
|
10.51 | 4.93 | 4.87 |
|
P/E
|
39.58 | 62.59 | 61.93 |
|
5yr Avg Cash Conversion Cycle
|
-144.61 Days | 49.91 Days | 58.21 Days |
|
Inventory Days
|
41.56 Days | 112.74 Days | 57.14 Days |
|
Days Receivable
|
27.36 Days | 105.72 Days | 50.92 Days |
|
Days Payable
|
155.82 Days | 255.1 Days | 66.69 Days |
|
5yr Average Interest Coverage Ratio
|
261.18 | 0.47 | 7.71 |
|
5yr Avg ROCE
|
17.15 % | -4.58 % | 18.52 % |
|
5yr Avg Operating Profit Margin
|
25.59 % | 10.74 % | 22.66 % |
|
5 yr average Debt to Equity
|
0.0 | -0.45 | 0.71 |
|
5yr CAGR Net Profit
|
-22.83 % | -7.77 % | 2.09 % |
|
5yr Average Return on Assets
|
14.73 % | -2.51 % | 9.05 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.82 % | 69.84 % | 43.43 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 3.68 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -28.23 % | -3.39 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.73 % | 15.18 % | -2.03 % |
|
Procter&Gamble Healt
|
Orchid Pharma
|
Aarti Inds
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
Segment Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|